Microbot Medical Inc. shares rise 1.92% premarket after Ramsay Health Care doubles Cairns Private Hospital's capacity for robotic-assisted joint surgeries.

Microbot Medical Inc. rose 1.92% in premarket trading. The news event related to Ramsay Health Care introducing a second ROSA orthopaedic robot at Cairns Private Hospital, which doubles the hospital's capacity for robotic-assisted joint surgeries, is likely to have a positive impact on the stock. The addition of a second unit means improved access to advanced technology for patients in Far North Queensland, which could potentially increase demand for Microbot Medical Inc.'s products.